ABSTRACT The TRP has recommended that the Global Fund Board approve Round 9 grants that, over their first two years, will cost $2.21 billion dollars. This makes Round 9 the second largest round ever of Global Fund grants.
After conducting its detailed review of Round 9 proposals, the Global Fund's Technical Review Panel (TRP) has recommended that the Global Fund Board approve grants that, over their first two years, will cost $2.21 billion dollars. This makes Round 9 the second largest round ever of Global Fund grants.
GFO has no information on which specific proposals the TRP has recommended for Board approval. But Board members have been informed by the Secretariat of some overall data. Highlights from what Board members were told, and from GFO's analysis of that information and of comparisons with earlier rounds, are as follows:
Round 9 results
| Proposals submitted to Global Fund | Of which, forwarded to TRP | Of which, recommended for approval | ||||||
| Number | Total cost | Number | Total cost | Number | Percentage | Total cost | Average cost | |
| HIV/AIDS | 80 | $2.38 b. | 73 | n/a | 30 | 41% | $0.75 b. | $25 m. |
| Malaria | 33 | $1.33 b. | 31 | n/a | 17 | 55% | $0.60 b. | $35 m. |
| TB | 57 | $1.17 b. | 53 | n/a | 32 | 60% | $0.50 b. | $16 m. |
| [HSS] | [n/a] | [n/a] | [33] | [n/a] | [17] | [49%] | [$0.36 b.] | [$21 m.] |
| Total | 170 | $4.88 b. | 157 | $4.8 b. | 96 | 51% | $2.21 b. | $23 m. |
Notes:
For comparison: Results from earlier rounds
| Proposals submitted to Global Fund | Of which, forwarded to TRP | Of which, approved | |||||||
| Number | Total cost | Number | Total cost | Number | Percentage | Total cost | Average cost | ||
| Round 8: | |||||||||
| HIV/AIDS | 83 | n/a | 76 | $3.0 b. | 37 | 49% | $1.16 b. | $31 m. | |
| Malaria | 43 | n/a | 41 | $2.0 b. | 28 | 68% | $1.57 b. | $56 m. | |
| TB | 59 | n/a | 57 | $1.1 b. | 29 | 51% | $0.33 b. | $11 m. | |
| Total | 185 | n/a | 174 | $6.1 b. | 94 | 54% | $3.06 b. | $33 m. | |
| Round 7: | |||||||||
| HIV/AIDS | n/a | 64 | $1.24 b. | 26 | 41% | $0.54 b. | $21 m. | ||
| Malaria | n/a | 45 | $0.84 b. | 28 | 62% | $0.47 b. | $17 m. | ||
| TB | n/a | 41 | $0.31 b. | 19 | 46% | $0.11 b. | $6 m. | ||
| Total | n/a | 150 | $2.40 b. | 73 | 49% | $1.12 b. | $15 m. | ||
| Round 6: | |||||||||
| HIV/AIDS | n/a | 82 | $1.31 b. | 32 | 39% | $0.45 b. | $14 m. | ||
| Malaria | n/a | 59 | $0.85 b. | 19 | 32% | $0.20 b. | $11 m. | ||
| TB | n/a | 55 | $0.36 b. | 34 | 62% | $0.19 b. | $6 m. | ||
| Total | n/a | 196 | $2.52 b. | 85 | 43% | $0.85 b. | $10 m. | ||
| Round 5: | |||||||||
| Total | n/a | 202 | $3.3 b. | 63 | 31% | $0.7 b. | $12 m. | ||
| Round 4: | |||||||||
| Total | n/a | 173 | $2.5 b. | 69 | 40% | $1.0 b. | $14 m. | ||
| Round 3: | |||||||||
| Total | n/a | 180 | $1.8 b. | 71 | 39% | $0.6 b. | $9 m. | ||
| Round 2: | |||||||||
| Total | n/a | 229 | $2.1 b. | 98 | 43% | $0.9 b. | $9 m. | ||
| Round 1: | |||||||||
| Total | n/a | 204 | $1.5 b. | 58 | 28% | $0.6 b. | $10 m. | ||
Note: Approved proposals do not include those initially rejected but eventually approved after appeal.
No comments yet. Be the first to comment!